2.730EUR+1.11%Mkt Cap: 204.59M EURP/E: —Last update: 2026-05-14
Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. Th…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)25.45
PEG—
P/B1.35
P/S1.42
EV/EBITDA71.40
EV/Revenue3.11
EPS (TTM)-0.73
EPS (Forward)0.11
Cash Flow & Leverage
FCF Yield-63.30%
FCF Margin-89.74%
Operating CF-1.56M EUR
CapEx (TTM)12.52M EUR
Net Debt/EBITDA38.85
Net Debt244.28M EUR
Technical
SMA 502.832 (-3.6%)
SMA 2002.903 (-6.0%)
Beta0.55
S&P 52W Chg24.23%
Avg Vol (30d)83.95K
Avg Vol (10d)75.48K
Technical Indicators
RSI (14)41.1
MACD-0.0453
MACD Signal-0.0291
MACD Hist.-0.0162
BB Upper3.046 EUR
BB Middle2.839 EUR
BB Lower2.632 EUR
BB Width14.58%
ATR (14)0.0932 EUR
Vol Ratio (20d)2.54x
52W Range
2.48023% of range3.590
52W High3.590 EUR
52W Low2.480 EUR
Profitability
Gross Margin43.51%
EBITDA Margin4.36%
Profit Margin-71.13%
Oper. Margin-41.77%
ROE-66.05%
ROA-20.30%
Revenue Growth5.10%
Earnings Growth—
Balance Sheet
Debt/Equity1.70
Current Ratio0.81
Quick Ratio0.16
Book Value/Sh2.001 EUR
Cash/Share0.1790 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.75.92M
Float38.41M
Insiders54.56%
Institutions5.60%
Analyst Consensus
Rating—
Target (Mean)4.833 EUR
Target Range4.000 EUR – 5.500 EUR
# Analysts3
Company
Market Cap204.59M EUR
Enterprise Value448.95M EUR
Revenue (TTM)144.31M EUR
Gross Profit61.35M EUR
Net Income (TTM)-100.30M EUR
Revenue/Share1.901 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees553
Last Price2.730 EUR
CountryES
SectorHealthcare
IndustryBiotechnology
ISIN—